
Capebel 500mg Tablet
Marketer
Shilpa Medicare Ltd
Salt Composition
Capecitabine (500mg)
Overview Capebel 500mg Tablet
Oncaspar 500mg tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional applications may be determined by a physician. Administered as part of a chemotherapy regimen, it can be used either alone or in conjunction with other medications. Oncaspar 500mg tablets should be ingested with food, within 30 minutes post-meal. Dosage and frequency are determined by the prescribing physician, dependent upon the specific condition and subject to change. Strict adherence to the physician's instructions is crucial; improper usage or overdose may lead to severe adverse reactions. While therapeutic benefits may not be immediately apparent (requiring weeks or months), discontinuation should only occur upon medical advisement. Common side effects include nausea, vomiting, abdominal discomfort, weakness, and diarrhea. A reduction in white blood cell count, increasing infection risk, is a potential consequence. Regular blood tests are essential to monitor blood cell counts, along with liver, kidney, and uric acid levels. Prior to commencement, disclose any pre-existing liver or kidney conditions, and all other medications, especially those used for infections; numerous drug interactions are possible. This medication is contraindicated during pregnancy and lactation. The utilization of effective contraception by both partners throughout treatment is vital to prevent conception.
Uses of Capebel 500mg Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of Capebel 500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 500mg Capebel tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Capebel 500mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Capebel 500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 500mg Capebel tablet whole; avoid crushing, chewing, or fracturing it. It should be administered with a meal.
How Capebel 500mg Tablet works:
Capebel 500mg tablets function as an anti-neoplastic agent. Metabolic processes transform the drug into 5-fluorouracil, which inhibits the production of vital genetic components (RNA and DNA) within cancerous cells. This disruption of cellular replication leads to decelerated tumor growth and ultimately, cell death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Capebel 500mg Tablet with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Capebel 500mg tablets during pregnancy poses a confirmed risk to the fetus, making it inadvisable. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
The use of Capebel 500mg tablets while breastfeeding is contraindicated due to potential infant toxicity.
DrivingUNSAFE
Taking a Capebel 500mg Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Capebel 500mg tablets cautiously, potentially requiring dosage modification under medical supervision. Capebel 500mg tablets are contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Capebel 500mg tablets cautiously, potentially requiring dosage modification under medical supervision. Capebel 500mg tablets are contraindicated in individuals with severe kidney disease.
What if you forget to take Capebel 500mg Tablet :
NA
Facts to Know About Capebel 500mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic inhibitors |
